| Role |
Name |
Disclosure |
Details |
| Author | Chris K Guerin, MD, FACE, Director, Diabetes Education Services, Chief, Division of Endocrinology, Tri-City Medical Center | Nothing to disclose | Details | | Coauthor | John L Boone, MD, Consulting Staff, Department of Otolaryngology, Naval Hospital Oak Harbor | Nothing to disclose | Details | | Medical Editor | Stephanie L Lee, MD, PhD, FACE, Director of Thyroid Disease Center, Department of Medicine, Associate Professor, Boston Medical Center, Boston University School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Kent Wehmeier, MD, Professor, Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St Louis University School of Medicine | Nothing to disclose | Details | | CME Editor | Mark Cooper, MD, Head, Vascular Division, Baker Medical Research Institute; Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Kent Wehmeier, Managing Editor |
The contributor discloses no conflict of interest. |
|